Japan Auto-Injectors For Glp-1 Receptor Agonists Market Outlook Report 2025-2 : Convenience And Compliance Boost Adoption As At-Home Delivery Methods Is Growing

2025-09-18 11:02:02

(MENAFN- GlobeNewsWire - Nasdaq) The Japan market for auto-injectors targeting GLP-1 receptor agonists is poised for growth, driven by rising cases of type 2 diabetes and obesity, increased prescription of these medications, and demand for convenient, at-home solutions. Innovations like smart injectors are enhancing patient compliance and adoption.

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Japan Auto-Injectors for Glp-1 Receptor Agonists Market Outlook 2038" report has been added to ResearchAndMarkets's offering.
Japan auto-injectors for GLP-1 receptor agonists market is valued at USD 137.7 million in 2025 and is expected to reach USD 292.9 million by 2038, rising at a CAGR of 6.1% over the forecast period from 2026 to 2038.

In 2026, the market size is projected to reach USD 143.8 million. The market for auto-injectors targeting GLP-1 receptor agonists in Japan is gaining momentum due to the rise in type 2 diabetes and obesity-related health complications. As these medications are increasingly prescribed for glycemic control and weight loss, demand for convenient, at-home delivery methods is growing.

Auto-injectors offer precise dosing, reduced needle anxiety, and enhanced patient compliance - making them a preferred solution among both patients and healthcare providers. Furthermore, Japan's aging population and shifting pharmaceutical delivery models are encouraging broader adoption of self-injection therapies. Innovation in device design, including smart injectors and wearable formats, is expected to further accelerate market uptake.
Key Topics Covered:

Japan Auto-Injectors for Glp-1 Receptor Agonists Market
Market Overview
Assumptions and Abbreviations
Research Methodology & Approach
Primary Research
Secondary Research
SPSS Methodology
Data Triangulation
Executive Summary
Value Chain Analysis
Auto-Injector Value Chain: From Materials to Market
Japan's Leading Auto-Injector Suppliers: Global Export Insights
Comparative Positioning
Competitive Landscape: Key Players
AstraZeneca
BECTON, DICKINSON AND COMPANY
ELI LILLY AND COMPANY
Nemera
Novo Nordisk A/S
Owen Mumford Pharmaceutical Services
SHL Medical AG
Sanofi
Ypsomed Holding AG
About the Publisher

Companies Featured

Novo Nordisk Japan
Eli Lilly Japan
Terumo Corporation
Sanofi Japan
AstraZeneca Japan
Fujifilm Holdings
Shionogi & Co.
Mitsubishi Tanabe Pharma
Daiichi Sankyo
Takeda Pharmaceutical
Otsuka Pharmaceutical
Sumitomo Pharma
Taisho Pharmaceutical
Kissei Pharmaceutical
Sysmex Corporation

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN18092025004107003653ID1110080514

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.